Portal Diabetes Gets FDA Breakthrough for Pump, Starts Insulin Study
17 Feb 2026
National
Portal Diabetes, Inc. ("Portal") announced its receipt of the Breakthrough Device Designation by the Food and Drug Administration (FDA) for its implantable insulin pump system called "Portal Pump," and the start of a Phase 1 study on its proprietary temperature-stable insulin ("Portal Insulin").
The Westfield, Indiana company aims to deliver a functional cure to type 1 diabetes-- an implantable insulin pump leveraging the physiologic delivery of insulin to the abdomen, modern continuous glucose monitoring (CGM) technology, and stable, concentrated insulin to fully close the loop on insulin delivery for patients living with type 1 diabetes.
More Topics
A new seafood market and restaurant is coming to downtown Westfield, bringing a fresh seafood concept to the city’s growing dining scene.Broad Ripple Seafood North and Bar is planned at the former Greek’s Pizzeria at 31 Park St. Owner Todd Reisenbigler said demolition is expected to begin in February, with...
2025 LIV Golf Economic Impact Report
Feb 4 2026In August of 2025, many of the world’s best golfers arrived in Westfield for a thrilling event that crowned the LIV Golf individual champion. The action on the course came down to the wire and ended with Jon Rahm hoisting the trophy at The Club at Chatham Hills. While Rahm...
H Steakhouse is a family affair for owner
Feb 1 2026H Steakhouse is set to open soon Feb. 7 at 207 Mill St. in downtown Westfield. Owned by veteran restaurateur Henri Najem, the restaurant is in many ways a family affair.Henri’s wife, Shelley, oversees interior design for the large building on two parcels on the corner of Mill and Jersey...